UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Lipidomic Profiles of the Heart and Circulation in Response to Exercise versus Cardiac Pathology: A Resource of Potential Biomarkers and Drug Targets

Cell reports (Cambridge), 2018-09, Vol.24 (10), p.2757-2772

2018

Volltextzugriff (PDF)

The yin and yang of adaptive and maladaptive processes in heart failure

Drug discovery today. Therapeutic strategies, 2012, Vol.9 (4), p.e163-e172

2012

Volltextzugriff (PDF)

The Interplay of Protein Coding and Non-Coding RNAs (circRNAs, lncRNAs) During Cardiac Differentiation

EBioMedicine, 2017-11, Vol.25 (C), p.9-10

2017

Volltextzugriff (PDF)

Pathophysiology of cardiac hypertrophy and heart failure: signaling pathways and novel therapeutic targets

Archives of Toxicology. Archiv für Toxikologie, 2015-09, Vol.89 (9), p.1401-1438

2015

Volltextzugriff (PDF)

Understanding Key Mechanisms of Exercise-Induced Cardiac Protection to Mitigate Disease: Current Knowledge and Emerging Concepts

Physiological reviews, 2018-01, Vol.98 (1), p.419-475

2018

Volltextzugriff (PDF)

Ibrutinib increases the risk of atrial fibrillation, potentially through inhibition of cardiac PI3K-Akt signaling

Blood, 2014-12, Vol.124 (25), p.3829-3830

2014

Volltextzugriff (PDF)

miRNA therapeutics: a new class of drugs with potential therapeutic applications in the heart

Future medicinal chemistry, 2015-01, Vol.7 (13), p.1771-1792

2015

Volltextzugriff (PDF)

The IGF1-PI3K-Akt Signaling Pathway in Mediating Exercise-Induced Cardiac Hypertrophy and Protection

Advances in experimental medicine and biology, 2017, Vol.1000, p.187-210

2017

Volltextzugriff (PDF)

PT353 Identification of miRNA networks in pathological cardiac remodelling-New therapeutic targets

Global heart, 2014-03, Vol.9 (1), p.e236-e236

2014

Volltextzugriff (PDF)

Translational Potential of Non-coding RNAs for Cardiovascular Disease

Non-coding RNAs in Cardiovascular Diseases, p.343-354

Volltextzugriff (PDF)

HDAC inhibition attenuates cardiac hypertrophy by acetylation and deacetylation of target genes

Epigenetics, 2015-05, Vol.10 (5), p.418-430

2015

Volltextzugriff (PDF)

Clusterin is regulated by IGF1–PI3K signaling in the heart: implications for biomarker and drug target discovery, and cardiotoxicity

Archives of toxicology, 2020-05, Vol.94 (5), p.1763-1768

2020

Volltextzugriff (PDF)

Novel Lipid Species for Detecting and Predicting Atrial Fibrillation in Patients With Type 2 Diabetes

Diabetes (New York, N.Y.), 2021-01, Vol.70 (1), p.255-261

2021

Volltextzugriff (PDF)

Sex differences in response to miRNA‐34a therapy in mouse models of cardiac disease: identification of sex‐, disease‐ and treatment‐regulated miRNAs

The Journal of physiology, 2016-10, Vol.594 (20), p.5959-5974

2016

Volltextzugriff (PDF)

Silencing of miR-34a attenuates cardiac dysfunction in a setting of moderate, but not severe, hypertrophic cardiomyopathy

PloS one, 2014-02, Vol.9 (2), p.e90337-e90337

2014

Volltextzugriff (PDF)

Therapeutic silencing of miR‐652 restores heart function and attenuates adverse remodeling in a setting of established pathological hypertrophy

The FASEB journal, 2014-12, Vol.28 (12), p.5097-5110

2014

Volltextzugriff (PDF)

The small-molecule BGP-15 protects against heart failure and atrial fibrillation in mice

Nature communications, 2014-12, Vol.5 (1), p.5705-5705, Article 5705

2014

Volltextzugriff (PDF)

The therapeutic potential of miRNAs regulated in settings of physiological cardiac hypertrophy

Future medicinal chemistry, 2014-02, Vol.6 (2), p.205-222

2014

Volltextzugriff (PDF)

Distinct lipidomic profiles in models of physiological and pathological cardiac remodeling, and potential therapeutic strategies

Biochimica et biophysica acta. Molecular and cell biology of lipids, 2018-03, Vol.1863 (3), p.219-234

2018

Volltextzugriff (PDF)

Inhibition of miR-154 Protects Against Cardiac Dysfunction and Fibrosis in a Mouse Model of Pressure Overload

Scientific reports, 2016-03, Vol.6 (1), p.22442-22442, Article 22442

2016

Volltextzugriff (PDF)

Identification of miR-34 regulatory networks in settings of disease and antimiR-therapy: Implications for treating cardiac pathology and other diseases

RNA biology, 2017-05, Vol.14 (5), p.500-513

2017

Volltextzugriff (PDF)

A brain-derived MeCP2 complex supports a role for MeCP2 in RNA processing

Bioscience reports, 2011-10, Vol.31 (5), p.333-343

2011

Volltextzugriff (PDF)

Estrogen receptor alpha deficiency in cardiomyocytes reprograms the heart-derived extracellular vesicle proteome and induces obesity in female mice

Nature Cardiovascular Research, 2023-03, Vol.2 (3), p.268-289

2023

Volltextzugriff (PDF)

Therapeutic potential of targeting microRNAs to regulate cardiac fibrosis: miR-433 a new fibrotic player

Annals of translational medicine, 2016-12, Vol.4 (24), p.548-548

2016

Volltextzugriff (PDF)

Early molecular correlates of adverse events following yellow fever vaccination

JCI insight, 2017-10, Vol.2 (19)

2017

Volltextzugriff (PDF)

1 – 25 von 25

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(21)

Publikationsform

Artikel
(25)

Sprache

Englisch
(25)

Erscheinungsjahr

n.n

Thema

Science & Technology
(23)
Life Sciences & Biomedicine
(20)
Animals
(18)
Mice
(11)
Humans
(8)
Male
(8)
Heart Failure
(7)
Biochemistry & Molecular Biology
(6)
Cardiomegaly - Metabolism
(6)
Disease Models, Animal
(6)
Physiology
(5)
Cardiomegaly - Physiopathology
(4)
Cell Biology
(4)
Female
(4)
Medicine, Research & Experimental
(4)
Micrornas - Genetics
(4)
Phosphatidylinositol 3-Kinases - Metabolism
(4)
Rats
(4)
Research & Experimental Medicine
(4)
Signal Transduction
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Lipidomic Profiles of the Heart and Circulation in Response to Exercise versus Cardiac Pathology: A Resource of Potential Biomarkers and Drug Targets

The yin and yang of adaptive and maladaptive processes in heart failure

The Interplay of Protein Coding and Non-Coding RNAs (circRNAs, lncRNAs) During Cardiac Differentiation

Pathophysiology of cardiac hypertrophy and heart failure: signaling pathways and novel therapeutic targets

Understanding Key Mechanisms of Exercise-Induced Cardiac Protection to Mitigate Disease: Current Knowledge and Emerging Concepts

Ibrutinib increases the risk of atrial fibrillation, potentially through inhibition of cardiac PI3K-Akt signaling

miRNA therapeutics: a new class of drugs with potential therapeutic applications in the heart

The IGF1-PI3K-Akt Signaling Pathway in Mediating Exercise-Induced Cardiac Hypertrophy and Protection

PT353 Identification of miRNA networks in pathological cardiac remodelling-New therapeutic targets

Translational Potential of Non-coding RNAs for Cardiovascular Disease

HDAC inhibition attenuates cardiac hypertrophy by acetylation and deacetylation of target genes

Clusterin is regulated by IGF1–PI3K signaling in the heart: implications for biomarker and drug target discovery, and cardiotoxicity

Novel Lipid Species for Detecting and Predicting Atrial Fibrillation in Patients With Type 2 Diabetes

Sex differences in response to miRNA‐34a therapy in mouse models of cardiac disease: identification of sex‐, disease‐ and treatment‐regulated miRNAs

Silencing of miR-34a attenuates cardiac dysfunction in a setting of moderate, but not severe, hypertrophic cardiomyopathy

Therapeutic silencing of miR‐652 restores heart function and attenuates adverse remodeling in a setting of established pathological hypertrophy

The small-molecule BGP-15 protects against heart failure and atrial fibrillation in mice

The therapeutic potential of miRNAs regulated in settings of physiological cardiac hypertrophy

Distinct lipidomic profiles in models of physiological and pathological cardiac remodeling, and potential therapeutic strategies

Inhibition of miR-154 Protects Against Cardiac Dysfunction and Fibrosis in a Mouse Model of Pressure Overload

Identification of miR-34 regulatory networks in settings of disease and antimiR-therapy: Implications for treating cardiac pathology and other diseases

A brain-derived MeCP2 complex supports a role for MeCP2 in RNA processing

Estrogen receptor alpha deficiency in cardiomyocytes reprograms the heart-derived extracellular vesicle proteome and induces obesity in female mice

Therapeutic potential of targeting microRNAs to regulate cardiac fibrosis: miR-433 a new fibrotic player

Early molecular correlates of adverse events following yellow fever vaccination

Suchergebnisse filtern